11/15
02:34 am
ttoo
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... [Yahoo! Finance]
Low
Report
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... [Yahoo! Finance]
11/14
04:17 pm
ttoo
T2 Biosystems Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
T2 Biosystems Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
11/14
04:05 pm
ttoo
T2 Biosystems Announces Third Quarter 2024 Financial Results
Medium
Report
T2 Biosystems Announces Third Quarter 2024 Financial Results
11/5
08:00 am
ttoo
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
Medium
Report
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
10/10
08:29 pm
ttoo
T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript [Seeking Alpha]
Low
Report
T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript [Seeking Alpha]
10/8
04:14 pm
ttoo
T2 Biosystems to Host Business Update Call on October 10, 2024 [Yahoo! Finance]
Medium
Report
T2 Biosystems to Host Business Update Call on October 10, 2024 [Yahoo! Finance]
10/8
04:05 pm
ttoo
T2 Biosystems to Host Business Update Call on October 10, 2024
Low
Report
T2 Biosystems to Host Business Update Call on October 10, 2024
10/8
09:00 am
ttoo
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform
Medium
Report
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform
10/7
09:17 am
ttoo
T2 Biosystems reports 35% rise in Q3 revenue [Seeking Alpha]
High
Report
T2 Biosystems reports 35% rise in Q3 revenue [Seeking Alpha]
10/7
09:05 am
ttoo
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
Medium
Report
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
10/7
09:00 am
ttoo
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results
Medium
Report
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results
9/23
09:00 am
ttoo
T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture
Medium
Report
T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture
9/20
09:00 am
ttoo
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
Low
Report
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
9/16
09:00 am
ttoo
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients
High
Report
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients
9/9
09:00 am
ttoo
T2 Biosystems Provides Updates on its New Product Development Pipeline Progress
Medium
Report
T2 Biosystems Provides Updates on its New Product Development Pipeline Progress
8/27
04:05 pm
ttoo
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference